Total Payments
$13,695
2024 Payments
$608.45
Companies
28
Transactions
129
Medicare Patients
8,528
Medicare Billing
$1.1M
Payment Breakdown by Category
Education$9,700 (70.8%)
Food & Beverage$2,250 (16.4%)
Travel$1,744 (12.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $9,700 | 5 | 70.8% |
| Food and Beverage | $2,250 | 120 | 16.4% |
| Travel and Lodging | $1,744 | 4 | 12.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $9,600 | 4 | $0 (2020) |
| The Spectranetics Corporation | $1,552 | 7 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $749.32 | 46 | $0 (2024) |
| ABIOMED | $377.85 | 2 | $0 (2024) |
| PFIZER INC. | $170.73 | 12 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $141.97 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $127.31 | 3 | $0 (2019) |
| Edwards Lifesciences Corporation | $126.69 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $102.36 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $95.89 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $608.45 | 21 | Novartis Pharmaceuticals Corporation ($260.46) |
| 2023 | $301.46 | 17 | Novartis Pharmaceuticals Corporation ($244.07) |
| 2022 | $95.68 | 6 | Novartis Pharmaceuticals Corporation ($78.55) |
| 2021 | $163.79 | 9 | PFIZER INC. ($47.94) |
| 2020 | $2,477 | 5 | AngioDynamics, Inc. ($2,400) |
| 2019 | $2,713 | 16 | AngioDynamics, Inc. ($2,400) |
| 2018 | $2,573 | 10 | AngioDynamics, Inc. ($2,400) |
| 2017 | $4,762 | 45 | AngioDynamics, Inc. ($2,400) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 08/06/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $58.24 | General |
| Category: Cardiovascular Device | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.36 | General |
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Obesity | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $126.69 | General |
| 04/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | Teleflex LLC | GUIDELINER (Device) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Interventional Access | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,035 | 2,740 | $837,218 | $281,522 |
| 2022 | 28 | 2,121 | 2,958 | $841,397 | $293,425 |
| 2021 | 30 | 2,267 | 3,088 | $838,572 | $300,920 |
| 2020 | 29 | 2,105 | 3,075 | $818,167 | $266,762 |
Total Patients
8,528
Total Services
11,861
Medicare Billing
$1.1M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 69 | 69 | $151,800 | $76,005 | 50.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 69 | 138 | $96,600 | $57,028 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 329 | $83,725 | $29,520 | 35.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 139 | 147 | $102,900 | $20,752 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 265 | 307 | $58,785 | $18,353 | 31.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 75 | 300 | $24,300 | $12,628 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $26,128 | $7,932 | 30.4% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 68 | 68 | $34,000 | $6,984 | 20.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 15 | $19,545 | $6,138 | 31.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 16 | 16 | $23,664 | $4,911 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 32 | $11,860 | $4,453 | 37.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 84 | 84 | $21,840 | $4,278 | 19.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 80 | 80 | $18,000 | $4,133 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 306 | 324 | $14,760 | $3,147 | 21.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $31,437 | $2,963 | 9.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 53 | 151 | $13,137 | $2,472 | 18.8% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 81 | 84 | $21,000 | $2,361 | 11.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 16 | 32 | $6,880 | $2,337 | 34.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 40 | $7,515 | $2,248 | 29.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $9,184 | $2,030 | 22.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $14,115 | $1,959 | 13.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 32 | 89 | $8,633 | $1,907 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 20 | $5,880 | $1,846 | 31.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 21 | 62 | $11,904 | $1,662 | 14.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $8,151 | $1,567 | 19.2% |
About Dr. Barath Krishnamurthy, MD
Dr. Barath Krishnamurthy, MD is a Cardiovascular Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962434498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barath Krishnamurthy, MD has received a total of $13,695 in payments from pharmaceutical and medical device companies, with $608.45 received in 2024. These payments were reported across 129 transactions from 28 companies. The most common payment nature is "Education" ($9,700).
As a Medicare-enrolled provider, Krishnamurthy has provided services to 8,528 Medicare beneficiaries, totaling 11,861 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Salem, OR
- Active Since 07/07/2006
- Last Updated 07/11/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962434498
Products in Payments
- EVLT (Device) $9,600
- CVX-300CVX-300P (Device) $1,285
- ENTRESTO (Drug) $494.00
- Impella (Device) $377.85
- TURBO POWER (Device) $267.09
- LEQVIO (Drug) $255.32
- ELIQUIS (Drug) $245.61
- BRILINTA (Drug) $127.31
- ROTABLATOR (Device) $110.46
- XARELTO (Drug) $95.89
- Corlanor (Drug) $58.59
- Optimizer (Device) $58.24
- (6575) Coronary Undivided (Device) $56.47
- Vascepa (Drug) $48.48
- IGT_D Coronary (Device) $45.89
- PRALUENT (Drug) $38.48
- PRADAXA (Drug) $35.12
- KENGREAL (Drug) $32.15
- GUIDELINER (Device) $27.02
- JARDIANCE (Drug) $23.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salem
Kevin Thompson, Do, DO
Cardiovascular Disease — Payments: $101,034
Cardiovascular Disease $101,034
Ashit Patel, M.d, M.D
Cardiovascular Disease — Payments: $54,451
Cardiovascular Disease $54,451
Dr. Sandeep Saha, M.d, M.D
Cardiovascular Disease — Payments: $43,942
Cardiovascular Disease $43,942
Dr. Andrew Maiolo, Md, MD
Cardiovascular Disease — Payments: $19,968
Cardiovascular Disease $19,968
Maziar Azadpour, M.d, M.D
Cardiovascular Disease — Payments: $17,622
Cardiovascular Disease $17,622
Deborah Hughes, M.d, M.D
Cardiovascular Disease — Payments: $10,535
Cardiovascular Disease $10,535